Corrections: Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data (The Lancet Respiratory Medicine (2017) 5(11) (881–890)(S2213260017303065)(10.1016/S2213-2600(17)30306-5));Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data

The Lancet Respiratory Medicine

Volumn 5, Issue 11, 2017, Pages 881-890

  Jolliffe, David A ^a   Greenberg, Lauren ^a   Hooper, Richard L ^a   Griffiths, Christopher J ^a   Camargo, Carlos A ^b   Kerley, Conor P ^c   Jensen, Megan E ^d   Mauger, David ^e   Stelmach, Iwona ^f   Urashima, Mitsuyoshi ^g   Martineau, Adrian R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUBLIN CITY UNIVERSITY   (Ireland)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CORTICOSTEROID; VITAMIN D; ANTIASTHMATIC AGENT; VITAMIN;

AGE; ARTICLE; ASTHMA; BODY MASS; DISEASE EXACERBATION; ETHNICITY; HUMAN; META ANALYSIS; POST HOC ANALYSIS; PRIORITY JOURNAL; RACE; SEX; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ADOLESCENT; ADULT; AGED; CHILD; DIETARY SUPPLEMENT; FEMALE; MALE; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; SECONDARY PREVENTION; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; SECONDARY PREVENTION; TREATMENT OUTCOME; VITAMIN D; VITAMINS; YOUNG ADULT;

EID: 85030478259     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(18)30208-X     Document Type: Erratum

References (33)

1. Global Asthma Network. The Global Asthma Report. http://www.globalasthmareport.org/resources/Global_Asthma_Report_2014.pdf, 2014 (accessed Sept 9, 2017).
2. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1459–1544.
3. Jackson, DJ, Johnston, SL, The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 125 (2010), 1178–1187.
4. Mukherjee, S, Lindell, DM, Berlin, AA, et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 179 (2011), 248–258.
5. Greiller, CL, Martineau, AR, Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 7 (2015), 4240–4270.
6. Nanzer, AM, Chambers, ES, Ryanna, K, et al. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1alpha,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J Allergy Clin Immunol 132 (2013), 297–304.
7. Brehm, JM, Acosta-Perez, E, Klei, L, et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am J Respir Crit Care Med 186 (2012), 140–146.
8. Salas, NM, Luo, L, Harkins, MS, Vitamin D deficiency and adult asthma exacerbations. J Asthma 51 (2014), 950–955.
9. Urashima, M, Segawa, T, Okazaki, M, Kurihara, M, Wada, Y, Ida, H, Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91 (2010), 1255–1260.
10. Majak, P, Olszowiec-Chlebna, M, Smejda, K, Stelmach, I, Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol 127 (2011), 1294–1296.
11. Castro, M, King, TS, Kunselman, SJ, et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA 311 (2014), 2083–2091.
12. Martineau, AR, MacLaughlin, BD, Hooper, RL, et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax 70 (2015), 451–457.
13. Yadav, M, Mittal, K, Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian J Pediatr 81 (2014), 650–654.
14. Tachimoto, H, Mezawa, H, Segawa, T, Akiyama, N, Ida, H, Urashima, M, Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy 71 (2016), 1001–1009.
15. Jensen, ME, Mailhot, G, Alos, N, et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials, 17, 2016, 353.
16. Kerley, CP, Hutchinson, K, Cormican, L, et al. Vitamin D3 for uncontrolled childhood asthma: a pilot study. Pediatr Allergy Immunol 27 (2016), 404–412.
17. Riverin, BD, Maguire, JL, Li, P, Vitamin D supplementation for childhood asthma: a systematic review and meta-analysis. PLoS One, 10, 2015, e0136841.
18. Xiao, L, Xing, C, Yang, Z, et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. Br J Nutr 114 (2015), 1026–1034.
19. Pojsupap, S, Iliriani, K, Sampaio, TZ, et al. Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis. J Asthma 52 (2015), 382–390.
20. Martineau, AR, Cates, CJ, Urashima, M, et al. Vitamin D for the management of asthma. Cochrane Database Syst Rev, 9, 2016 CD011511.
21. Luo, J, Liu, D, Liu, CT, Can vitamin D supplementation in addition to asthma controllers improve clinical outcomes in patients with asthma?: a meta-analysis. Medicine (Baltimore), 94, 2015, e2185.
22. Fares, MM, Alkhaled, LH, Mroueh, SM, Akl, EA, Vitamin D supplementation in children with asthma: a systematic review and meta-analysis. BMC Res Notes, 8, 2015, 23.
23. Martineau, AR, Jolliffe, DA, Hooper, RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ, 356, 2017, i6583.
24. Lehouck, A, Mathieu, C, Carremans, C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 156 (2012), 105–114.
25. Martineau, AR, James, WY, Hooper, RL, et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 3 (2015), 120–130.
26. Stewart, LA, Clarke, M, Rovers, M, et al. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA 313 (2015), 1657–1665.
27. Higgins, JP, Altman, DG, Gotzsche, PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 343, 2011, d5928.
28. Reddel, HK, Taylor, DR, Bateman, ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 180 (2009), 59–99.
29. Riley, RD, Lambert, PC, Abo-Zaid, G, Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ, 340, 2010, c221.
30. DerSimonian, R, Laird, N, Meta-analysis in clinical trials. Control Clin Trials 7 (1986), 177–188.
31. Department of Health. Department of Health report on health and social subjects, no. 49. Nutrition and bone health with particular reference to calcium and vitamin D, 1998, The Stationery Office, London.
32. Peters, JL, Sutton, AJ, Jones, DR, Abrams, KR, Rushton, L, Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 61 (2008), 991–996.
33. Guyatt, GH, Oxman, AD, Vist, GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.